ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1410

Prolotherapy Versus Corticosteroid Injections  and Phonophoresis for the Treatment of Plantar Fasciitis: A Randomized Controlled Trial 

Gulseren Demir1, Muyesser Okumus2, Aynur Karagoz3 and Turgut Kultur4, 1Clinic of PMR, Health Ministry Ankara Training and Research Hospital, Ankara, Turkey, 2Department of Physical Medicine and Rehabilitation, Kirikkale University Faculty of Medicine, Kırıkkale, Turkey, 3Dept of Physical Medicine and Rehabilitation, Ministry of Health, Ankara Training and Research Hospital, Ankara, Turkey, 4University of Kirikkale, Faculty of Medicine, Department of Physical Medicine and Rehabilitation, Assistant Professor, Kirikkale, Turkey

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: foot disorders, musculoskeletal sonography, physical therapy, tendonitis/bursitis and treatment options

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2015

Title: Orthopedics, Low Back Pain and Rehabilitation Poster

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Proximal plantar fasciitis is the most common cause of plantar heel pain in adults. Plantar fasciitis is a degenerative syndrome of the plantar fascia resulting from repeated trauma at its origin on the calcaneus. Prolotherapy  has evolved as a new treatment option for refractory Plantar Fascitis.   In this study we compared the efficacy of prolotherapy versus corticosteroid injection and phonophorezis for the treatment plantar fasciitis.

Methods: A hundred and fifty patients with clinically determined plantar fasciitis were recruited.  Patients were assigned to receive dextrose prolotherapy, corticosteroid injection or corticosteroid phonophoresis for treatment of plantar fasciitis. The first group underwent at baseline followed by a second injection 2 weeks later. The second group was performed local corticosteroid injection as single dose and the third group  received phonophoresis. All patients were given an exercise program. Heel Sensitivity Index (THI), Visual Analogue Scale (VAS),  Foot Function Index (FFI), Foot and Ankle Outcome Score (FAOS) and SF-36 were measured at baseline and at 1 and 3 months’ follow-up. Besides plantar fascia thickness was measured by Ultrasonography (USG) before treatment, 1 and 3 months after treatment.

Results: Within each group, the analysis demonstrated statistically significant improvements in all parameters from baseline to 1 and 3 months (p <0.05). There was no significant difference  between groups in terms of efficacy of treatment (p> 0.05).  Aside from injection-associated pain, no adverse reactions were reported. The plantar fascial thickness between the baseline and final measurements revealed a mean decrease in thickness, statistically significant difference (p <0.05) in three groups.  Between groups before treatment, 1 and 3 months after treatment in terms of plantar fascia thickness there was no statistically significant difference (p> 0.05). (Table 1)

Table 1. The Distribution of Plantar Fascia Thickness of between Treatment Groups and  within Each Group

Plantar fascia thickness

Before treatment

A month after treatmant

Three months after treatment

p

Mean±S

Mean±S

Mean±S

Prolotherapy

5,45±1,04bc

3,43±1,33

3,53±1,41

<0,001

Corticosteroid Injection

5,31±1,07bc

3,22±1,24

3,74±1,36

<0,001

Phonophoresis

5,37±0,93bc

3,56±1,28

3,92±1,49

<0,001

p

0,728

0,369

0,451

 

bIn post-hoc pairwise comparisons result of “Post-Therapy First Month” with no significant difference was found.

c In post-hoc pairwise comparisons result of “Post-Therapy Third Month” with no significant difference was detected..

Conclusion: Prolotherapy, corticosteroid  and phonophorosis therapies were generally well tolerated and appeared to provide benefit of patients with plantar fasciitis. As a result prolotherapy can be an effective way to treat plantar fasciitis


Disclosure: G. Demir, None; M. Okumus, ..., 2; A. Karagoz, None; T. Kultur, None.

To cite this abstract in AMA style:

Demir G, Okumus M, Karagoz A, Kultur T. Prolotherapy Versus Corticosteroid Injections  and Phonophoresis for the Treatment of Plantar Fasciitis: A Randomized Controlled Trial  [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/prolotherapy-versus-corticosteroid-injections-and-phonophoresis-for-the-treatment-of-plantar-fasciitis-a-randomized-controlled-trial/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/prolotherapy-versus-corticosteroid-injections-and-phonophoresis-for-the-treatment-of-plantar-fasciitis-a-randomized-controlled-trial/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology